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6Abstract 
Objectives The project aimed to determine 
the level of medication compliance in patients having 
a chronic condition and to determine the types and 
frequency of medication-related problems identified by a 
pharmacist working in a community pharmacy.  
 
Method The study population was identified from 
the database of patients receiving free medicinals under 
the ‘Pharmacy of your Choice’ scheme from a particular 
community pharmacy.  Patients included in the study were 
older than 60 years of age and taking more than 3 drugs.  
A Compliance Questionnaire was distributed to these 
patients.  The pharmacist classified medication problems 
and used a specifically developed data collection tool in 
order to collate all the relevant patient information.  
Key findings Of the 75 patients included in the 
study, 33 (44%) said they never missed a dose whilst 
the remaining 42 (56%) were non-compliant. Out of the 
205 medication-related problems identified, the most 
common medication-related problems observed were 
non-compliance (56%) and the occurence of adverse drug 
reactions (55%).  
Conclusion Compliance is a significant 
medication-related problem encountered by community 
pharmacists amongst elderly patients receiving multiple 
drug therapy for their chronic conditions.
Keywords compliance, medication-related 
problems, chronic conditions, POYC.
Introduction
Chronic conditions are diseases of long duration and 
generally slow progression. They are conditions that can 
only be controlled and not, at present, cured.  Chronic 
conditions, such as cardiac disease, cancer, chronic 
respiratory diseases, stroke and diabetes, are by far the 
leading cause of mortality in the world, representing 60% 
of all deaths.  The major risk factors for chronic disease are 
an unhealthy diet, lack of physical exercise and tobacco 
use.1  
Living with a chronic disease has a significant impact on 
a person’s quality of life.  The incidence of such diseases 
increases with age.  In fact, many older people are living 
with more than one chronic condition meaning that they 
face different challenges, both medical and social.2  One 
of the most prominent medical challenges is compliance 
to medication. Since older people tend to be consuming a 
number of medications, they keep forgetting when their 
next medication is due, or which drug they are supposed 
to be taking at that time. 
Medication compliance refers to the degree or extent of 
conformity to the recommendations about daily treatment 
by the health care professional with respect to the timing, 
dosage, and frequency.3 It may be defined as “the extent 
to which a patient acts in accordance with the prescribed 
interval, and dose of a dosing regimen”. 4   
 
Another medical challenge faced particularly by the 
elderly is that of medication errors.  A medication-related 
problem is an event or situation whereby drug therapy 
is negatively interfering with the patient’s health.  These 
problems can cause, contribute or aggravate common 
geriatric problems. Pharmacists can identify and prevent 
medication-related problems through careful evaluation 
and monitoring of patients’ drug regimens.5
The aims of this study were to determine the level of 
medication compliance in patients having a chronic 
condition and to determine the types and frequency of 
medication-related problems identified by a pharmacist 
working in a community pharmacy.
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Method
The study population was identified from the database of 
patients receiving free medicinals under the ‘Pharmacy of 
your Choice’ (POYC) scheme from a particular community 
pharmacy. Patients included in the study were older 
than 60 years of age and taking more than 3 different 
drugs under the scheme. Seventy-five eligible patients 
participated in this study after signing an informed 
consent form. Ethics approval for the study was granted by 
the University of Malta Ethics Committee.  
The study was divided into three sections. The first 
part consisted of proposing a Maltese version of the 
‘Compliance Questionnaire’ which was previously 
developed by Letizia Zammit in 2005 as part of her 
undergraduate pharmacy project.6 The Maltese version 
of the questionnaire was validated by an expert panel 
consisting of a general practitioner, a pharmacist, a head 
of school, a university lecturer specialising in the Maltese 
language and a lay person.
The second part of the study saw the implementation 
of the questionnaire to the 75 patients when they called 
at the pharmacy to collect their medicine. The third 
part dealt with the pharmacist identifying medication 
problems. The pharmacist classified the medication 
problems and developed a data collection tool in order to 
collate all the relevant patient information.  This included 
demographic data, drug history, past medical history, 
current diagnosis, any recent clinical parameters and the 
potential medication problems, which were classified into: 
sub-optimal dosing, over-dosing, therapeutic duplication, 
unnecessary medication, clinically significant interactions 
and non-compliance.
Results
Out of the 75 patients involved in the study, 46 (61%) 
were female and 29 (39%), were male.  The average age of 
the patients was 74, whilst the median age was 72.  The 
patients age ranged between 60 and 88 years of age, 
with 30 (40%) being within the 60-69 age bracket and 
45 (60%) being over 70 years of age. Sixty-eight (91%) of 
the patients were married, 36 (48%) patients were living 
with other members of their family, 23 (31%) were living 
alone and 16 (21%) were retired in an institution. Patients’ 
educational level ranged from 28 (37%) having completed 
5-9 years of full-time education, 26 (35%) patients 
completed up to 4 years of education, whilst the remaining 
21 (28%) accomplished more than 10 years of education. 
All patients but six (8%) were born in Malta. The majority 
(88%) of patients said they visit the same doctor each time. 
For those living in an institution (21%), this would happen 
automatically since one doctor would be responsible for 
that home. 
Compliance Issues
Sixty-six patients (88%) said they usually visit the same 
doctor.  Regarding compliance to medications, 33 patients 
(44%) said they never missed a dose, 24 (32%) would rarely 
miss their medication, 15 (20%) missed a dose once a week 
whilst the remaining 3 (4%) patients always missed a dose. 
Reasons for non-compliance were various. From the non-
compliant group, 19 (25%) claimed to be asymptomatic, 
13 (17%) experienced side-effects related to their chronic 
disease medication, 3 (4%) showed lack of concern whilst 
7 (9%) did not comply since they forgot to take their 
medication.        
   
When asked what action patients take upon realizing they 
had missed a dose, 24 (32%) admitted to skipping the dose 
altogether, 15 (20%) said they took the dose when they 
remembered and 3 (4%) said they took double the dose at 
the next dose. 
  
Compliance with the prescribed times of medications 
is also an important factor in determining patient 
compliance.  Patients were asked whether they were 
compliant with the prescribed times of their medications.  
The majority of patients (64%) took their medications at 
the prescribed times.
8Medication-Related Problems
The pharmacist identified 205 medication-related 
problems in the drug treatment of the 75 patients. The 
most common were non-compliance (42), the occurrence 
of adverse drug reactions (41), subtherapeutic dose (26) 
and risk of drug interactions (25) (Figure 1). 
Discussion
The majority of patients in this study 56% (n=42) were 
non-compliant and the reasons given correlate well with 
results reported by Corlett in 1996 where non-compliance 
was reported to result from patients not knowing how to 
take the medication, not understanding the importance 
of drugs in managing the symptoms, polypharmacy, 
anticipation or experience of side-effects, forgetfulness or 
impaired physical function.7 In the scenario of this study a 
reason for non-compliance was inaccess to free medicines. 
      
When the medicine is out of stock from government 
stocks the risk of non-compliance is higher since patients 
are either too old to go to collect their supply from the 
Government pharmacy, are not eager to wait long hours 
in the queue at the Government pharmacy or have no 
relatives to send to pick up their medications.  Most 
patients are unwilling to buy the out-of-stock medications 
resulting in the patients not taking their medications, 
increasing the problem of non-compliance.  
       
Pharmacists have a pivotal role in optimizing compliance 
to pharmacotherapy and therefore improve health 
outcomes by assessing each patient individually.  This will 
result in assessing each patient’s own compliance problem, 
recommending targeted interventions that are responsive 
to the patients’ risk factors and needs, identifying 
predisposing factors and providing comprehensive  
counseling.8      
 
The pharmacist spends time educating the patients 
in order to increase the level of drug compliance and 
after identifying individual drug related problems the 
pharmacist can focus the counselling to address this area 
or contact the prescriber to follow-up patient care. Such 
interventions by the community pharmacist add value 
to the level of care provided to patients receiving their 
medicines through the POYC scheme and contribute to 
improving patient safety and patient outcomes.
The most prominent medication-related problem as 
identified by the pharmacist in this study was non-
compliance in 56% (n=42) of patients, followed by the 
incidence of adverse drug reactions or side effects in 
55% (n=41) of patients.  This finding coincides well with 
results from other studies.9, 10,11 In the case of older adults, 
adverse drug reactions may contribute to already existing 
geriatric problems such as increasing risk of falls, urinary 
incontinence, constipation and weight loss.  
       
Conclusion
Results indicated the importance of educating patients 
regarding compliance since only 44% claimed to be 
compliant at all times. The elderly may tend to be 
more non-compliant since they would not understand 
the dosage regimen and would be unaware of the 
consequences of poor compliance.6  Elderly qualify as 
a patient group to undergo regular treatment review 
sessions by the community pharmacist when collecting 
the medications for chronic diseases. This review 
will reinforce information about the drugs, identify 
medication-related problems and reduce non-compliance 






only 44% claimed 
to be compliant at 
all times”
JOURNAL OF EUROMED PHARMACY 
9
References
1. World Health Organization. 2008-2013 Action Plan for 
the Global Strategy for the Prevention and Control of Non-
communicable diseases. Alwan A., April 2008 [updated 
2010; cited 2010 Jan 10].Available from: http://www.who.
int/topics/chronic_diseases/en/
2. Naughton C, Bennett K, Feely J. Prevalence of chronic 
disease in the elderly based on a national pharmacy claims 
database. Age Aging 2006; 35(6): 633-636
3. Düsing R, Lottermoser K, Mengden T.  Compliance with 
drug therapy – new answers to an old question.  Nephrol 
Dial Transplant 2001; 16(7):1317-21
4. Cramer JA, Rosenheck R, Kirk G, Krol W and Krystal J. 
Medication Compliance Feedback and Monitoring in 
a Clinical Trial: Predictors and Outcomes.  Value Health 
2003;6(5):566-73
5. Fialová D, Onder G. Medication errors in elderly people: 
contributing factors and future perspectives. Br J Clin 
Pharmacol. 2009;67(6):641-5
Figure 1: Classification and frequency of medication-related problems (n=205).
6. Zammit L.  Compliance Issues in Hypertensive Care 
[dissertation].  Msida (Malta):  University of Malta; 2005.
7. Cramer JA. Enhancing patient compliance in the elderly. 
Role of packaging aids and monitoring. Drugs Aging. 1998; 
12(1):7-15
8. Nichols-English G, Poirier S.  Optimizing adherence 
to pharmaceutical care plan.  J Am Pharm Assoc. 
2000;40(4)475-85
9. Vervloet D, Durham S.  Adverse reactions to drugs.  BMJ 
1998; 316(7143):1511-4
10. Budnitz DS, Pollock DA, Weidenbach KN et al. National 
surveillance of emergency department visits for outpatient 
adverse drug events. JAMA. 2006; 296:1858–66.
11. Vassilev Z, Chu A, Ruck B, Adams E and Marcus S.  
Evaluation of Adverse Drug Reactions Reported to a Poison 
Control Center between 2000 and 2007.  Am J of Health 
Syst Pharm. 2009;66(5):481-7
